Enhabit, Inc. Files 8-K
Ticker: EHAB · Form: 8-K · Filed: Dec 4, 2024 · CIK: 1803737
Sentiment: neutral
Topics: sec-filing, 8-k, regulation-fd
TL;DR
Enhabit filed a standard 8-K, no new info.
AI Summary
Enhabit, Inc. filed an 8-K on December 4, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements for this form type.
Why It Matters
This filing indicates Enhabit, Inc. is meeting its regulatory reporting obligations with the SEC. It does not provide new operational or financial information that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a routine SEC disclosure and does not contain any new material information that would pose an immediate risk.
Key Players & Entities
- Enhabit, Inc. (company) — Registrant
- Encompass Health Home Health Holdings, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing for Enhabit, Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as required by the SEC.
On what date was this 8-K report filed?
This 8-K report was filed on December 4, 2024.
What is Enhabit, Inc.'s principal executive office address?
Enhabit, Inc.'s principal executive office is located at 6688 N. Central Expressway, Suite 1300, Dallas, Texas 75206.
What was Enhabit, Inc.'s former company name?
Enhabit, Inc.'s former company name was Encompass Health Home Health Holdings, Inc.
What is Enhabit, Inc.'s IRS Employer Identification Number?
Enhabit, Inc.'s IRS Employer Identification Number is 47-2409192.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2024-12-04 16:58:08
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share EHAB New York Stock Exchange
Filing Documents
- ehab-20241204.htm (8-K) — 26KB
- exhibit991-20241232024pres.htm (EX-99.1) — 15KB
- 0001803737-24-000201.txt ( ) — 169KB
- ehab-20241204.xsd (EX-101.SCH) — 2KB
- ehab-20241204_lab.xml (EX-101.LAB) — 22KB
- ehab-20241204_pre.xml (EX-101.PRE) — 13KB
- ehab-20241204_htm.xml (XML) — 3KB
01. Regulation FD Disclosure.*
Item 7.01. Regulation FD Disclosure.* A copy of the press release issued by the Company and Encompass Health Corporation (the "Plaintiffs") on December 4, 2024, announcing an award of damages and other relief to the Plaintiffs in a lawsuit filed in the Delaware Court of Chancery is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press release dated December 4 , 2024 (furnished herewith).* 104 Cover Page Interactive Data File - the cover page iXBRL tags are embedded within the Inline XBRL document * The information contained in Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K is being "furnished" with the Securities and Exchange Commission and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that section. Furthermore, such information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, unless specifically identified as being incorporated therein by reference.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized. ENHABIT, INC. By: /s/ Dylan C. Black Name: Dylan C. Black Title: General Counsel Dated: December 4, 2024